Indivior Pharmaceuticals

INDV

----

Current ValuationThe current P/E ratio is 11.53, below the reasonable range, cheaper than 94.25% of the time in the past 1 years, and the industry ranks 14/256, the industry Median -1.15.

11.53xP/E

Stock price$34.79Earnings per share$3.02

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

0306090120

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x20x40x60x80x100x

P/E ratio
Name/Symbol
BMYUSBristol Myers Squibb	13.45x	52.98%	$124.85B
GSKUSGSK	15.85x	16.02%	$101.93B
UCBJYUSUCB S.A.	17.96x	--	$45.69B
OTSKYUSOtsuka Pharmaceutical	15.97x	--	$41.36B
ZTSUSZoetis	12.48x	6.68%	$32.90B
DSNKYUSDaiichi Sankyo	19.39x	--	$32.58B
ALPMYUSAstellas Pharma	12.05x	--	$28.11B
JAZZUSJazz Pharma	14.63x	266.27%	$13.76B
OPHLYUSOno Pharmaceutical	15.13x	--	$7.37B
INDVUSIndivior Pharmaceuticals	11.53x	126.83%	$4.11B
HYPMYUSHypera S.A.	11.27x	--	$3.72B
OGNUSOrganon	17.28x	211.11%	$3.61B
SNPHYUSSanten Pharmaceutical	14.55x	--	$3.60B
PBHUSPrestige Brands	13.20x	7.48%	$2.27B
HRMYUSHarmony Biosciences	12.31x	45.72%	$2.23B
ANIPUSANI Pharma	16.30x	51.20%	$1.62B
PAHCUSPhibro Animal Health	15.98x	27.16%	$1.59B
GTBIFUSGreen Thumb Industries Inc.	12.03x	--	$1.52B
CRONUSCronos	17.85x	944.31%	$1.25B
AMPHUSAmphastar Pharma	14.19x	6.90%	$1.11B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.